Abstract:Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and mortality globally. Despite the remarkable improvements in comprehensive HCC treatment, the underlying mechanistic details of HCC remain elusive. We screened HCC patients for differentially expressed genes (DEGs) using the Gene Expression Omnibus (GSE113850) and The Cancer Genome Atlas (TCGA) datasets.LINC01554expression in 40 paired samples was determined by quantitative reverse transcription polymerase chain reaction (RT-qPCR), and its clinical significance was assessed.LINC01554was found to have a gain-of-function role in HCCin vitro. Additionally, the bioinformatics analysis of the genes co-expressed withLINC01554was performed using the Co-LncRNA website, and potential molecular mechanisms were investigated using the Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes resources and validated byin vitroexperiments. A total of 229 DEGs were identified from the GSE113850 dataset. Among the identified DEGs, three long non-coding RNAs (lncRNAs) (DIO3OS, LINC01554, andLINC01093) with |logFC| >= 2 and PLINC01554expression levels were significantly correlated with overall survival, pathological stage, hepatitis B infection, tumour size, portal vein tumour thrombus, and TNM stage. Using gain-of-function assays, we further showed thatLINC01554inhibited the proliferation, migration, and invasion of the HCCLM9 and SK-Hep1 cells and promoted G0/G1 arrest, but it did not significantly affect apoptosis. Western blotting revealed thatLINC01554overexpression resulted in increased ZO-1 and E-cadherin expression levels, but decreased N-cadherin and vimentin expression levels. Moreover,LINC01554overexpression inhibited Akt, p-Akt, beta-catenin, and p-Gsk3 beta expression. Our results showed thatLINC01554repressed HCC cell invasiveness and epithelial-to-mesenchymal transition partly by inhibiting Wnt and PI3K-Akt signallingin vitro. Taken together, our findings provide new insights into the molecular mechanisms underlying HCC tumourigenesis and implicateLINC01554as a potential target for HCC therapy.

Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression

LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway

LINC01608 Activated by YY1 Facilitate Hepatocellular Carcinoma Progression by Modulating the EGFR/ERK Axis.

LINC00152 Promotes Cell Cycle Progression in Hepatocellular Carcinoma Via Mir-193A/b-3p/ccnd1 Axis

Long Noncoding RNA LINC00665 is a Diagnostic Biomarker That Enhances Cell Proliferation and Migration in Hepatocellular Carcinoma.

LINC00857 contributes to hepatocellular carcinoma malignancy via enhancing epithelial-mesenchymal transition.

LINC00978 Promotes the Progression of Hepatocellular Carcinoma by Regulating EZH2-mediated Silencing of P21 and E-cadherin Expression

LINC00152 Promotes Proliferation in Hepatocellular Carcinoma by Targeting EpCAM Via the Mtor Signaling Pathway

LINC00624 affects hepatocellular carcinoma proliferation and apoptosis through the miR‐342‐3p/DNAJC5 axis

Long Non-coding RNA 02298 Promotes the Malignancy of HCC by Targeting the miR-28-5p/CCDC6 Pathway

LINC00844 Promotes Proliferation and Migration of Hepatocellular Carcinoma by Regulating NDRG1 Expression

Bioinformatics analysis of<i>LINC01554</i>and its co-expressed genes in hepatocellular carcinoma

Lnc-UCID promotes G1/S transition and hepatoma growth by preventing DHX9-mediated CDK6 downregulation.

LINC00978 Promotes Hepatocellular Carcinoma Carcinogenesis Partly Via Activating the MAPK/ERK Pathway

Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using the Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction

LINC02870 Facilitates SNAIL Translation to Promote Hepatocellular Carcinoma Progression.

Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma.

LINC00963 Promotes Hepatocellular Carcinoma Progression by Activating PI3K/AKT Pathway

LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis

Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway.

Long Noncoding Rna Linc01123 Promotes The Proliferation And Invasion Of Hepatocellular Carcinoma Cells By Modulating The Mir-34a-5p/Tuft1 Axis